These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 8204875)
21. [Results and experiences with a modified BFM protocol for treatment of recurrences in children with acute lymphoblastic leukemia in East German areas]. Sauerbrey A; Zintl F; Malke H; Reimann M; Maaser M; Domula M; Dörffel W; Eggers G; Exadaktylos P; Kotte W Klin Padiatr; 1993; 205(4):281-7. PubMed ID: 8377448 [TBL] [Abstract][Full Text] [Related]
22. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica. Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi A; Miniero R; Di Tullio MT; Lo Nigro L; Pession A; Rondelli R; Messina C; Santoro N; Mori PG; De Rossi G; Tamaro P; Silvestri D; Biondi A; Basso G; Masera G Haematologica; 1998 Sep; 83(9):791-9. PubMed ID: 9825576 [TBL] [Abstract][Full Text] [Related]
24. [The efficacy of BFM-90 program in the treatment of acute lymphoblastic leukemia in children in the studies of Polish pediatric leukemia/lymphoma group]. Chybicka A; Bogusławska-Jaworska J; Gorczyńska E; Juszczak K; Armata J; Balcerska A; Balwierz W; Bubała H; Filiks-Litwin B; Kołecki P; Kowalczyk J; Lukowska K; Matysiak M; Rokicka-Milewska R; Rola-Kurc E; Stencel D; Sońta-Jakimczyk D; Strojny W; Wachowiak J; Wieczorek M; Wysocki M; Zelenay E Wiad Lek; 1998; 51 Suppl 4():25-32. PubMed ID: 10731940 [TBL] [Abstract][Full Text] [Related]
25. CNS-directed therapy in young children with T-lineage acute lymphoblastic leukemia: High-dose methotrexate versus cranial irradiation. Nathan PC; Maze R; Spiegler B; Greenberg ML; Weitzman S; Hitzler JK Pediatr Blood Cancer; 2004 Jan; 42(1):24-9. PubMed ID: 14752790 [TBL] [Abstract][Full Text] [Related]
26. Intermediate dose methotrexate is as effective as high dose methotrexate in preventing isolated testicular relapse in childhood acute lymphoblastic leukemia. Dördelmann M; Reiter A; Zimmermann M; Fengler R; Henze G; Riehm H; Schrappe M J Pediatr Hematol Oncol; 1998; 20(5):444-50. PubMed ID: 9787317 [TBL] [Abstract][Full Text] [Related]
27. The prognosis and survival of childhood acute lymphoblastic leukemia with central nervous system relapse. Unal S; Yetgin S; Cetin M; Gümrük F; Arslan D; Ozyürek E; Tuncer M; Topçu M Pediatr Hematol Oncol; 2004; 21(3):279-89. PubMed ID: 15202168 [TBL] [Abstract][Full Text] [Related]
28. ALL-REZ BFM--the consecutive trials for children with relapsed acute lymphoblastic leukemia. Henze G; v Stackelberg A; Eckert C Klin Padiatr; 2013 May; 225 Suppl 1():S73-8. PubMed ID: 23700062 [TBL] [Abstract][Full Text] [Related]
29. An intensive re-treatment protocol for children with an isolated CNS relapse of acute lymphoblastic leukemia. Ribeiro RC; Rivera GK; Hudson M; Mulhern RK; Hancock ML; Kun L; Mahmoud H; Sandlund JT; Crist WM; Pui CH J Clin Oncol; 1995 Feb; 13(2):333-8. PubMed ID: 7844594 [TBL] [Abstract][Full Text] [Related]
30. Comparison of maintenance treatment regimens for first central nervous system relapse in children with acute lymphocytic leukemia. A Pediatric Oncology Group study. Land VJ; Thomas PR; Boyett JM; Glicksman AS; Culbert S; Castleberry RP; Berry DH; Vats T; Humphrey GB Cancer; 1985 Jul; 56(1):81-7. PubMed ID: 3859359 [TBL] [Abstract][Full Text] [Related]
31. Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991). Kamps WA; Bökkerink JP; Hählen K; Hermans J; Riehm H; Gadner H; Schrappe M; Slater R; van den Berg-de Ruiter E; Smets LA; de Vaan GA; Weening RS; van Weerden JF; van Wering ER; den der Does-van den Berg A Blood; 1999 Aug; 94(4):1226-36. PubMed ID: 10438710 [TBL] [Abstract][Full Text] [Related]
32. Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group. Matloub Y; Lindemulder S; Gaynon PS; Sather H; La M; Broxson E; Yanofsky R; Hutchinson R; Heerema NA; Nachman J; Blake M; Wells LM; Sorrell AD; Masterson M; Kelleher JF; Stork LC; Blood; 2006 Aug; 108(4):1165-73. PubMed ID: 16609069 [TBL] [Abstract][Full Text] [Related]
33. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster. Schrappe M; Reiter A; Zimmermann M; Harbott J; Ludwig WD; Henze G; Gadner H; Odenwald E; Riehm H Leukemia; 2000 Dec; 14(12):2205-22. PubMed ID: 11187912 [TBL] [Abstract][Full Text] [Related]
34. Improvement in CNS protective treatment in non-high-risk childhood acute lymphoblastic leukemia: report from the Japanese Children's Cancer and Leukemia Study Group. Tsurusawa M; Katano N; Yamamoto Y; Hirota T; Koizumi S; Watanabe A; Takeda T; Hatae Y; Yatabe M; Mimaya J; Gushiken T; Nishi K; Anami K; Kikuta A; Kanegane H; Asami K; Nishikawa K; Sekine I; Kawano Y; Iwai A; Furuyama T; Ijichi O; Miyake M; Mugishima H; Fujimoto T Med Pediatr Oncol; 1999 Apr; 32(4):259-6. PubMed ID: 10102019 [TBL] [Abstract][Full Text] [Related]
35. Treatment of CNS relapse in children with acute lymphoblastic leukemia: A Pediatric Oncology Group study. Winick NJ; Smith SD; Shuster J; Lauer S; Wharam MD; Land V; Buchanan G; Rivera G J Clin Oncol; 1993 Feb; 11(2):271-8. PubMed ID: 8426204 [TBL] [Abstract][Full Text] [Related]
36. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy. Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303 [TBL] [Abstract][Full Text] [Related]
37. Prophylaxis and treatment of neoplastic meningeosis in childhood acute lymphoblastic leukemia. Schrappe M; Reiter A; Riehm H J Neurooncol; 1998; 38(2-3):159-65. PubMed ID: 9696367 [TBL] [Abstract][Full Text] [Related]
38. The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: a report from the Childrens Cancer Group. Cherlow JM; Steinherz PG; Sather HN; Gaynon PS; Grossman NJ; Kersey JH; Johnstone HS; Breneman JC; Trigg ME; Hammond GD Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1001-9. PubMed ID: 8262820 [TBL] [Abstract][Full Text] [Related]
39. Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01. Waber DP; Turek J; Catania L; Stevenson K; Robaey P; Romero I; Adams H; Alyman C; Jandet-Brunet C; Neuberg DS; Sallan SE; Silverman LB J Clin Oncol; 2007 Nov; 25(31):4914-21. PubMed ID: 17971588 [TBL] [Abstract][Full Text] [Related]
40. Improved outcome for acute lymphoblastic leukemia in children of a developing country: results of the Chilean National Trial PINDA 87. Campbell M; Salgado C; Quintana J; Becker A; Vargas L; Cabrera ME; Beresi V; Rojas J; Paez E; Tapia S; Zolezzi P; Advis P Med Pediatr Oncol; 1999 Aug; 33(2):88-94. PubMed ID: 10398182 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]